Global serum proteomic changes in water buffaloes infected with Fasciola gigantica

[1]  Matthias Selbach,et al.  Picky: a simple online PRM and SRM method designer for targeted proteomics , 2018, Nature Methods.

[2]  Xing-Quan Zhu,et al.  Expression profiles of genes involved in TLRs and NLRs signaling pathways of water buffaloes infected with Fasciola gigantica , 2018, Molecular immunology.

[3]  Junjeong Choi,et al.  Evaluation of the Expression of Amine Oxidase Proteins in Breast Cancer , 2017, International journal of molecular sciences.

[4]  Xing-Quan Zhu,et al.  Serum levels of cytokines in water buffaloes experimentally infected with Fasciola gigantica. , 2017, Veterinary parasitology.

[5]  Xing-Quan Zhu,et al.  Comparative proteomic analysis of virulent and avirulent strains of Toxoplasma gondii reveals strain-specific patterns , 2017, Oncotarget.

[6]  C. Duval,et al.  Fibrinogen splice variation and cross-linking: Effects on fibrin structure/function and role of fibrinogen γ' as thrombomobulin II. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[7]  Xing-Quan Zhu,et al.  Proteomic Differences between Developmental Stages of Toxoplasma gondii Revealed by iTRAQ-Based Quantitative Proteomics , 2017, Front. Microbiol..

[8]  Xing-Quan Zhu,et al.  Transcriptomic responses of water buffalo liver to infection with the digenetic fluke Fasciola gigantica , 2017, Parasites & Vectors.

[9]  X. Suo,et al.  Global iTRAQ-based proteomic profiling of Toxoplasma gondii oocysts during sporulation. , 2016, Journal of proteomics.

[10]  Luis A. Marcos,et al.  Association of Fasciola hepatica Infection with Liver Fibrosis, Cirrhosis, and Cancer: A Systematic Review , 2016, PLoS neglected tropical diseases.

[11]  Ross S Hall,et al.  Time-Course Study of the Transcriptome of Peripheral Blood Mononuclear Cells (PBMCs) from Sheep Infected with Fasciola hepatica , 2016, PloS one.

[12]  J. Dalton,et al.  A prospective view of animal and human Fasciolosis , 2016, Parasite immunology.

[13]  C. Chai,et al.  Overexpression of vascular adhesion protein‐1 is associated with poor prognosis of astrocytomas , 2016, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  Xing-Quan Zhu,et al.  Proteomic Profiling of Mouse Liver following Acute Toxoplasma gondii Infection , 2016, PloS one.

[15]  A. Heck,et al.  Reconciling proteomics with next generation sequencing. , 2016, Current opinion in chemical biology.

[16]  J. Dalton,et al.  The Fasciola hepatica genome: gene duplication and polymorphism reveals adaptation to the host environment and the capacity for rapid evolution , 2015, Genome Biology.

[17]  C. Mingala,et al.  Evidence of Fasciola spp. resistance to albendazole, triclabendazole and bromofenofos in water buffaloes (Bubalus bubalis). , 2015, Annals of parasitology.

[18]  B. Liu,et al.  A novel targeted proteomics method for identification and relative quantitation of difference in nitration degree of OGDH between healthy and diabetic mouse , 2014, Proteomics.

[19]  R. Ariëns.  Fibrin(ogen) and thrombotic disease , 2013, Journal of thrombosis and haemostasis : JTH.

[20]  P. Reitsma,et al.  New fundamentals in hemostasis. , 2013, Physiological reviews.

[21]  D. Kavanagh,et al.  CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver , 2012, Journal of hepatology.

[22]  J. Utzinger,et al.  Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[23]  T. Nozaki,et al.  Novel Transmembrane Receptor Involved in Phagosome Transport of Lysozymes and β-Hexosaminidase in the Enteric Protozoan Entamoeba histolytica , 2012, PLoS pathogens.

[24]  H. Sharifiyazdi,et al.  Molecular characterization of human Fasciola samples in Gilan province, Northern Iran on the basis of DNA sequences of ribosomal and mitochondrial DNA genes , 2012, Comparative Clinical Pathology.

[25]  H. Elovaara,et al.  Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. , 2011, Blood.

[26]  Y. Toiyama,et al.  Serum soluble vascular adhesion protein‐1 is a valuable prognostic marker in gastric cancer , 2011, Journal of surgical oncology.

[27]  C. Michiels,et al.  Food applications of bacterial cell wall hydrolases. , 2011, Current opinion in biotechnology.

[28]  S. Jalkanen,et al.  Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. , 2009, Blood.

[29]  P. Zipfel,et al.  Complement regulators and inhibitory proteins , 2009, Nature Reviews Immunology.

[30]  Jennifer Keiser,et al.  Food-Borne Trematodiases , 2009, Clinical Microbiology Reviews.

[31]  Y. Toiyama,et al.  Circulating form of human vascular adhesion protein‐1 (VAP‐1): Decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis , 2009, Journal of surgical oncology.

[32]  S. Mas‐Coma,et al.  Chapter 2. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. , 2009, Advances in parasitology.

[33]  Wei Li,et al.  Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-Å structure of the heparin-bridged complex , 2008, Proceedings of the National Academy of Sciences.

[34]  John D. Lambris,et al.  Complement evasion by human pathogens , 2008, Nature Reviews Microbiology.

[35]  D. Acosta,et al.  Discovery and validation of serum biomarkers expressed over the first twelve weeks of Fasciola hepatica infection in sheep , 2007, International Journal for Parasitology.

[36]  M. Neerman-Arbez,et al.  Molecular mechanisms accounting for fibrinogen deficiency: from large deletions to intracellular retention of misfolded proteins , 2007, Journal of thrombosis and haemostasis : JTH.

[37]  S. Thiel,et al.  New perspectives on mannan-binding lectin-mediated complement activation. , 2007, Immunobiology.

[38]  W. Kanoksil,et al.  Endoscopic removal of one live biliary Fasciola gigantica. , 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[39]  T. Okanoue,et al.  A case of human fasciolosis: discrepancy between egg size and genotype of Fasciola sp , 2006, Parasitology Research.

[40]  M. Herbster,et al.  Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum , 2006, The Lancet.

[41]  J. Hope,et al.  Humoral and cellular immune responses to Fasciola gigantica experimental infection in buffaloes. , 2006, Research in veterinary science.

[42]  John D Lambris,et al.  Generation of C5a in the absence of C3: a new complement activation pathway , 2006, Nature Medicine.

[43]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[44]  S. Jalkanen,et al.  Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. , 2005, Immunity.

[45]  Susumu Goto,et al.  The KEGG resource for deciphering the genome , 2004, Nucleic Acids Res..

[46]  Darren A. Natale,et al.  The COG database: an updated version includes eukaryotes , 2003, BMC Bioinformatics.

[47]  C. Grimm,et al.  A novel GlcNAcα1-HPO3-6Gal(1-1)ceramide antigen and alkylated inositol-phosphoglycerolipids expressed by the liver fluke Fasciola hepatica , 2003 .

[48]  N. Anderson,et al.  The Human Plasma Proteome: History, Character, and Diagnostic Prospects , 2003, Molecular & Cellular Proteomics.

[49]  C. Grimm,et al.  A novel GlcNAcalpha1-HPO3-6Gal(1-1)ceramide antigen and alkylated inositol-phosphoglycerolipids expressed by the liver fluke Fasciola hepatica. , 2003, Glycobiology.

[50]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[51]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[52]  T. Fujita.  Evolution of the lectin–complement pathway and its role in innate immunity , 2002, Nature Reviews Immunology.

[53]  R. Geyer,et al.  The Liver Flukes Fasciola gigantica and Fasciola hepatica Express the Leucocyte Cluster of Differentiation Marker CD77 (Globotriaosylceramide) in Their Tegument , 2001, Biological chemistry.

[54]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[55]  I. Fairweather,et al.  Fasciolicides: efficacy, actions, resistance and its management. , 1999, Veterinary journal.

[56]  D. Adams,et al.  Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. , 1998, Journal of immunology.

[57]  C. Boulard,et al.  Humoral and cellular immune responses to Fasciola hepatica experimental primary and secondary infection in sheep. , 1995, International journal for parasitology.

[58]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[59]  M. Peitsch,et al.  Assembly of macromolecular pores by immune defense systems. , 1991, Current opinion in cell biology.

[60]  W. Duffus,et al.  Killing of juvenile Fasciola hepatica by purified bovine eosinophil proteins. , 1980, Clinical and experimental immunology.

[61]  J. Williams.  Fascioliasis , 1961 .